SCHEMBL6646342

SCHEMBL6646342

O=[N+]([O-])c1ccc2c(c1)NC(=S)C1CCCC21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.50
NOS1 P29475 2/20 0.50
NOS2 P35228 2/20 0.50
ABCC8 Q09428 1/20 0.42
KCNJ11 Q14654 1/20 0.42
CHRNB4 P30926 3/20 0.40
CHRNA3 P32297 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 2/20 0.40
HSP90AA1 P07900 1/20 0.40
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
CHRNA7 P36544 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CHRM1 P11229 1/20 0.38
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
KDM1A O60341 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6643304 0.89 NOS3 (0.50) NOS3NOS1NOS2ABCC8KCNJ11
SCHEMBL6643026 0.84 NOS3 (0.51) NOS3NOS1NOS2ABCC8KCNJ11
SCHEMBL6640660 0.76 MAPK1 (0.37) NOS3NOS1NOS2MAPTLMNA
SCHEMBL6642761 0.75 NOS3 (0.44) NOS3NOS1NOS2MAPTCHRM1
SCHEMBL6644155 0.74 LMNA (0.43) NOS3NOS1NOS2ABCC8KCNJ11
SCHEMBL6641968 0.73 NOS3 (0.51) NOS3NOS1NOS2ABCC8KCNJ11
SCHEMBL6641453 0.71 NOS3 (0.48) NOS3NOS1NOS2ABCC8KCNJ11
SCHEMBL6641777 0.71 NOS3 (0.55) NOS3NOS1NOS2CHRNB4CHRNA3
SCHEMBL6645884 0.67 EGFR (0.42) NOS3NOS1NOS2MAPTHSP90AA1
SCHEMBL6642348 0.67 TDP2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054869-B1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AG (DE) 2004-09-22 EP disclosed
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 US disclosed